Apr 22, 2019 | In The News
Diasome’s Liver Targeted Insulin was reported by Martin Hensel for InsulinNation.com, 18 April 2019. Nanotechnology insulin additive improves action profiles and potentially reduces required doses, according to the report. In normal human physiology, the liver...